<PAGE>
/------------------------------/
/ OMB APPROVAL /
/------------------------------/
/ OMB Number: 3235-0104 /
/ Expires: September 30, 1998 /
/ Estimated average burden /
/ hours per response...... 0.5 /
/------------------------------/
+--------+
| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION
+--------+ Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Wesley Jessen VisionCare, Inc. ("WJ")
----------------------------------------------------------------------------
(Last) (First) (Middle)
333 East Howard Avenue
----------------------------------------------------------------------------
(Street)
Des Plaines Illinois 60018-5903
----------------------------------------------------------------------------
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year) 3/19/00
--------------
3. IRS or Social Security Number of Reporting Person
(Voluntary)
--------------
4. Issuer Name and Ticker or Trading Symbol Ocular Sciences, Inc. ("OSI")
Nasdaq - "OCLR"
-----------------------------------
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
X
___ Director ___ Officer ___ 10% Owner ___ Other
(give title below) (specify below)
----------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
----------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X
____ Form Filed by One Reporting Person
____ Form filed by More than One Reporting Person
Table I--Non-Derivative Securities Beneficially Owned
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------
1. Title 2. Amount of 3. Ownership Form: 4. Nature of
of Securities Bene- Direct (D) or Indirect Bene-
Security ficially Owned Indirect (I) ficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 5)
- --------------------------------------------------------------------------------
<S> <C> <C> <C>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
*If the form is filed by more than one reporting person, see instruction
5(b)(v).
SEC 1473 (7-96)
<PAGE>
FORM 3 (continued)
Table II--Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Date Exer- 3. Title and Amount of Securities 4. Conversion 5. Ownership 6. Nature of In-
Security (Instr. 4) cisable and Underlying Derivative Security or Form of direct Bene-
Expiration (Instr. 4) Exercise Derivative ficial
Date Price Security: Ownership
(Month/Day/ of Direct (D) (Instr. 5)
Year) Derivative or In-
---------------------------------------------------- Security direct (I)
Date Expira- Amount or (Instr. 5)
Exer- tion Title Number of
cisable Date Shares
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Option (Right to Purchase) (a) (b) Common Stock 4,5557,830 16.94 D(c)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(a) The option referenced above was granted in connection with an Agreement and
Plan of Merger, dated March 19, 2000, among WJ, OSI and OSI Acquisition Corp.
The option is not currently exercisable. The option may be exercised by WJ at
any time after the occurrence of an event the result of which is that the total
fee required to be paid to WJ pursuant to Section 7.2(a) of the merger agreement
equals $20.0 million.
(b) The option is scheduled to expire upon the earlier of: (i) the effective
time of the merger, (ii) six months after the first occurrence of an event that
entitles WJ to receive the termination fee set forth in the merger agreement,
(iii) the termination of the merger agreement under circumstances in which no
termination fee is payable or (iv) 12 months after the date the merger agreement
is terminated if WJ is entitled to receive termination fees under Section
7.2(c)(A) thereof.
(c) WJ expressly disclaims beneficial ownership of all shares of OSI Common
Stock that may be purchased upon exercise of the option.
Wesley Jessen VisionCare, Inc.
/s/ Edward J. Kelley 3/28/00
------------------------------- -----------------
**Signature of Reporting Person Date
Name: Edward J. Kelley
Title: Chief Financial Officer
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB number.
Page 2
SEC 1473 (7-96)
